Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

MPC Container Ships ASA announces date for Q1 and three-month 2022 results

Oslo, 13 May 2022 - MPC Container Ships ASA (the "Company") will be releasing its first quarter 2022 report prior to market opening on Thursday 19 May 2022. The Company will host a webcast for the presentation of the Q1 2022 results commencing on Thursday 19 May 2022 at 15:00 hours CEST / 09:00 hours EDT. The presentation will be made available on the Company’s webpage from 12:00 hours CET / 06:00 hours EDT. There will be a Q&A session after the presentation. The event is being streamed. It is recommended that you listen via your

First Camp Group Interim report Q1 2022

First Camp, Scandinavia’s largest campsite chain, increased revenues in the first quarter of 2022 by 48% vs same period in 2021, adjusted for effects from acquisitions (pro forma).The first quarter 2022 (same quarter last year in brackets) · Total revenue of SEK 59.2 million (26.0) · Pro forma revenue increased with 48% compared to Q1 2021 · Pro forma Adjusted EBITDA amounted to SEK -52.6 million (-55.5) · EBIT amounted to SEK -75.1 million (-44.0) · Cash flow from operating activities of SEK 16.5 million (-8.5) · Establishment on the Norwegian market through the

Hansa Biopharma announces temporary marketing authorization in Switzerland for Idefirix[®] (imlifidase) in kidney transplantation

· Approval by Swissmedic[1] enables highly sensitized patients in Switzerland to receive Idefirix[®] treatment prior to kidney transplantation · Idefirix[®] is now granted marketing authorization within the EU, the U.K.*, Israel and Switzerland Lund, Sweden May 13, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today announces that the Swiss Agency for Therapeutic Products (Swissmedic) has granted temporary marketing authorization for Idefirix[®] in adult patients with a positive crossmatch against an

Senior management and key employees in Bactiguard have acquired call options in Bactiguard issued by the main owners, comprising shares corresponding to 4 percent of all shares in Bactiguard

The Board of Directors in Bactiguard Holding AB (publ)  has been informed by the company’s main owners, Christian Kinch, Thomas von Koch and Jan Ståhlberg, that senior management and key employees in Bactiguard have acquired call options in Bactiguard issued by the three main owners, comprising shares corresponding to 4 per cent of all shares in Bactiguard.The company’s main owners have offered senior management (including two board members) and key employees in Bactiguard to acquire call options in Bactiguard issued by the main owners. In total 1 504 795 call

Enersense’s subsidiary Megatuuli and Valorem enter into a co-operation agreement on 1,500 MW wind power development projects in Finland

Enersense International Plc   Press release, 13 May 2022 at 9:00 a.m.Greenfield wind power developer Megatuuli Oy, a subsidiary of Enersense International Plc, a provider of zero-emission energy solutions, and French green energy company Valorem have signed a mutual co-operation agreement targeting to develop 1,500 MW worth of wind power projects in Finland by 2025. Reaching the goal would bring new investments to Finland totaling 1.5 billion EUR. The term of the agreement spans three years and covers the companies’ current mutual wind power projects in addition to new wind power

Safello Publishes Interim Report for Q1 2022

Stockholm, 13 May 2022 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the first quarter of 2022. The report can be found on safello.com/ir . The quarter was characterized by strengthening of the position through the new Crypto-as-a-Service offering, announced in conjunction with the LOI with Avanza. Net turnover increased by +5% compared to the first quarter in the prior year and amounted to SEK 205.2 million (194.7). Gross profit decreased by -19% and amounted to SEK 8.5 million (10.5).  “With the announcement

Veidekke: To build Costco’s first warehouse in Scandinavia

Veidekke's subsidiary Arcona has been commissioned by Costco Wholesale to build Scandinavia's first Costco warehouse in Arninge, near Stockholm. The project is an execution contract that comprises tenant adaptation of 14,000 square metres. The work starts now and continues until October. The contract has a value of approximately SEK 145 million.Costco's first Swedish warehouse is already under construction by Arcona. The new contract comprises tenant adaptation of the building, which is soon to be completed and certified to the environmental standard Miljöbyggnad Silver. The warehouse will

Setra Group invests in TC kilns from Valutec to two swedish sawmills

Just under two years ago, Setra Hasselfors became the first sawmill within the Setra Group to invest in Valutec TC drying technology. Now they are investing in new TC wood drying kilns for both Hasselfors and the sawmill in Heby, both located in Sweden. “The properties of the TC continuous kiln fit well into the Setra Greenness philosophy. They offer the precision of the batch kiln in combination with high capacity and efficient heat recovery. Another bonus with it is that we don’t get tied to one batch size if we’d like to switch to larger ones in the future to reduce handling and further

Smartoptics announces DCP-404 muxponder for 100G aggregation into 400G DWDM

Oslo, Norway – May 13, 2022 – Smartoptics (Euronext: SMOP), a leading provider of optical networking solutions, today announced the release of the DCP-404 muxponder  for 100G aggregation into 400G DWDM. The DCP-404 delivers ease of use, cost efficiency and low latency to network operators, positioning it for metro networks.The DCP-404 is a layer 1, OpenZR+-capable muxponder with support for four 100G client links and 400G in the line interface. This gives network operators the flexibility to deploy 100G, 200G, 300G or 400G DWDM.

Kamux Corporation’s Interim Report for January 1 - March 31, 2022: Kamux’s revenue grew strongly at +13.1%, adjusted operating profit (EBIT) was at the previous year’s level

Kamux Corporation Interim Report 13.5.2022 at 09:00 Kamux Corporation’s Interim Report for January 1 - March 31, 2022: Kamux’s revenue grew strongly at +13.1%, adjusted operating profit (EBIT) was at the previous year’s level This is a summary of Kamux Corporation's Interim Report for January 1 - March 31, 2022. The complete report is attached to this release and is also available at the company website at www.kamux.com. The figures in parentheses refer to the comparison period, i.e., the same period in the previous year, unless stated otherwise. January—March in brief ·

ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2022

MAINTAINED SALES LEVEL WITH SATISFACTORY PROFITABILITYRevenues during the first quarter of 2022 amounted to SEK 334.4 (333.4) million, which corresponded to 0.3% (38.0%) growth compared with the corresponding period last year. The EBITDA result amounted to SEK 25.8 (37.3) million and the EBITDA margin to 7.7% (11.2%). It showed that the company managed to maintain sales levels combined with good profitability despite the impact of external conditions with increased costs related to raw materials and transport, covid outbreaks among distributors and effects of the war between Russia and

Interim report January – March 2022

Oslo, Norway, May 13, 2022 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the period January 1 – March 31, 2022. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Genetic Analysis CEO Ronny Hermansen comments:“As we look back on the first quarter of 2022, I am proud of all the milestones we’ve achieved in these few months. I often say that we are focused on building momentum supporting our vision to become a global leading diagnostic company within the microbiome field

Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto

Herantis Pharma Plc Company release 13 May 2022 at 9:00am EEST    Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Antti Vuolanto Position: Other senior manager   Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 14854/5/4 ____________________________________________   Transaction date: 2022-05-10 Venue not applicable Instrument type: SHARE ISIN: FI4000087861 Nature of the

Herantis Pharma Oyj: Managers' Transactions – Timo Veromaa

Herantis Pharma Plc Company release 13 May 2022 at 9:00am EEST   Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Timo Veromaa Position: Member of the Board/Deputy member   Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 14847/5/4 ____________________________________________   Transaction date: 2022-05-10 Venue not applicable Instrument type: SHARE ISIN: FI4000087861 Nature of

Herantis Pharma Oyj: Managers' Transactions – Frans Wuite

Herantis Pharma Plc Company release 13 May 2022 at 9:00am EEST   Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Frans Wuite Position: Chief Executive Officer   Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 14848/5/4 ____________________________________________   Transaction date: 2022-05-10 Venue not applicable Instrument type: SHARE ISIN: FI4000087861 Nature of the

Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle

Herantis Pharma Plc Company release 13 May 2022 at 9:00am EEST   Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tone Kvåle Position: Chief Financial Officer   Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 14850/5/4 ____________________________________________   Transaction date: 2022-05-10 Venue not applicable Instrument type: SHARE ISIN: FI4000087861 Nature of the

Konecranes Plc’s Board of Directors convenes the Annual General Meeting 2022

KONECRANES PLC STOCK EXCHANGE RELEASE May 13, 2022 at 9:00 am EEST   Konecranes Plc’s Board of Directors convenes the Annual General Meeting 2022   Notice to the Annual General Meeting   Notice is given to the shareholders of Konecranes Plc ("Konecranes" or the "Company") to the Annual General Meeting to be held on Wednesday 15 June 2022 at 10.00 a.m. EEST at Hyvinkääsali (address: Kauppatori 1, FI-05800 Hyvinkää, Finland). Reception of persons registered for the meeting and distribution of voting tickets will commence at 9.15 a.m. EEST   Due to the still ongoing

Anora publishes historical pro forma financial information for the new reporting segments

Anora Group Plc   Stock Exchange Release   13 May 2022 at 8:30 am EET Anora publishes historical pro forma financial information for the new reporting segments Anora publishes historical pro forma financial information for the new reporting segments for the year 2021. Anora Group Plc was formed when the merger of Altia and Arcus was completed on 1 September 2021. Arcus has been consolidated to Anora as of 1 September 2021. After the merger, Anora designed a new operating model for the Group that enables Anora to build on its strong platform in the Nordics, expand to international

REVENUE MAINTAINED DESPITE MARKET DECLINE, WHILE EARNINGS REDUCED BY STRONG HEADWINDS FROM COST PRESSURES

REVENUES FROM CONTINUING OPERATIONS WERE UP 0.6% COMPARED TO Q1 2021, WHILE ADJUSTED EBIT WAS REDUCED TO EUR 7.6 MILLION BY THE ONGOING DISRUPTIONS IN THE AUTOMOTIVE SUPPLY CHAIN AND THE ABNORMALLY HIGH COSTS OF E-COMPONENTS, RAW MATERIALS AND FREGHT.Zurich, May 13, 2022: Kongsberg Automotive ASA (“Kongsberg Automotive”) has published its results for the first quarter 2022 today. The results show resilience in the face of difficult market conditions. All the financial information in this press release refers to the continuing operations of the company, as the ICS and LDC business are

Nordic Nanovector ASA: Results for the First Quarter 2022

Oslo, Norway, 13 May 2022 Nordic Nanovector ASA (OSE: NANOV) announces its results for the first quarter 2022. A presentation by Nordic Nanovector’s senior management team will be held in-person today in Oslo and webcast live beginning at 8:30am CET – details below. Erik Skullerud, CEO of Nordic Nanovector, said: “The impacts from COVID-19 continued to linger during Q1 and meant the pick-up in recruitment into PARADIGME that we expected has not yet materialised. Nonetheless, we remain highly committed to completing patient recruitment for this important trial and expect to meet our

Vår Energi ASA announces pricing of Senior Notes Offering

Sandnes, Norway, 13 May 2022: Vår Energi ASA (OSE: VAR, the “Company”) is pleased to announce that it has priced its offering (the “Offering”) of USD 500 million aggregate principal amount of 5.000% Senior Notes due 2027 (the “Notes”) at a price equal to 99.961% of the aggregate principal amount thereof. Interest will be payable semi-annually. The Offering is expected to close on or about May 18, 2022, subject to customary conditions precedent for similar transactions. In connection with the Offering, the initial purchasers may engage in stabilising transactions with a view to supporting

Kesko’s sales grew in April

Kesko Group's sales totalled €998.7 million in April 2022, representing an increase of 3.1% on the previous year. In comparable terms, sales grew by 2.5%."In April, Kesko’s sales grew in the grocery trade division and the building and technical trade division. Food trade sales were at a good level, with strong growth in foodservice. In building and technical trade, sales growth continued strong despite the fact that Easter this year was in April. The division had one delivery day less than the year before,” says Kesko's President and CEO Mikko Helander. Sales in the grocery trade

Raisio plc’s consumer business in Russia transferred to the new owner

Raisio plc, Stock Exchange Release, May 13, 2022 The transaction of Raisio plc’s consumer business in Russia to Copacker Agro Ltd has been completed. The Russian authorities have registered the transaction on May 12, 2022 and the business of Raisio plc’s subsidiary OOO Raisio Nutrition has been transferred to the buyer, Copacker Agro Ltd. Raisio signed agreements to sell consumer business in Russia on April 29, 2022. According to the agreement OOO Raisio Nutrition, the subsidiary responsible for Raisio’s consumer business in Russia, was sold to the Russian company Copacker Agro Ltd.

Six lithium dose predictors for patients with bipolar disorder

Six predictors could help determine the amount of lithium needed to treat patients with bipolar disorder, according to a large study led by researchers at Karolinska Institutet in Sweden. The study, published in the journal The Lancet Psychiatry, also pinpoints genetic markers that seem to influence how quickly the body eliminates lithium from its system.“Our model could already now be used to predict how much lithium a patient with bipolar disorder will need. This could cut valuable time spent on finding the right dose for each patient, potentially with life-saving impact,” says Martin

There are no items matching the current filter
There are no more items matching the current filter
Back to top